You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 7, April 12, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Psychiatry
 •Depression
 •Adverse Effects
 •Alert me on articles by topic

Sex Hormone Deficiency in Depressed Patients Receiving Opioids

Since this article does not have an abstract, we have provided the first 145 words of the full text and any section headings.

Since depression is a common symptom of sex-hormone deficiency and hypogonadism is quickly induced by opioid medications, the review of the relationships between pain and depression by Bair et al1 might logically have included a discussion of opioid-induced androgen deficiency (OPIAD). Opioids inhibit gonadotropin production in most men soon after beginning therapy with sustained-action oral,2 transdermal,3 or intrathecal4 opioids. A similar illness is present but less well documented in opioid-treated women.3-4

Depression in patients with OPIAD seems likely to reflect, at least in part, the influence of exogenous opioids on the endorphin-dependent depression-related pathways discussed by Bair et al.1

In my experience, depression in men with OPIAD often responds poorly to selective serotonin reuptake inhibitors or to other antidepressant medications until testosterone deficiency is treated with appropriate hormone therapy or until opioid use has been decreased to a level that allows resolution of androgen deficiency.

Harry W. Daniell, MD
Reading, Calif

1. Bair M, Robinson R, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163:2433-2445. FREE FULL TEXT
2. Daniell H. Hypogonadism in men consuming sustained-action oral opioids. J Pain. 2002;3:377-384. FULL TEXT | ISI | PUBMED
3. Daniell H. The association of endogenous hormone levels and exogenously administered opiates in males. Am J Pain Manage. 2001;11:8-10.
4. Abs R, Verhelst J, Maeyaert J, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab. 2000;85:2215-2222. FREE FULL TEXT

Arch Intern Med. 2004;164:804.


RELATED ARTICLE

Depression and Pain Comorbidity: A Literature Review
Matthew J. Bair, Rebecca L. Robinson, Wayne Katon, and Kurt Kroenke
Arch Intern Med. 2003;163(20):2433-2445.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.